PAR1 is a thrombin-responsive GPR and its stimulation causes an enhancement in MALT1 protease activity in both osteosarcoma and breast cancer cells, potentially associating with other aggressive phenotypes [22]. The gene discussed is ALDH18A1; the disease is breast cancer.